Good Morning Trader!


In an era defined by rapid technological advancements, the integration of Artificial Intelligence (AI) stands as a beacon of hope in transforming the healthcare landscape. With its unparalleled ability to process vast amounts of data and derive actionable insights, AI holds the promise of revolutionizing healthcare by addressing existing inefficiencies and overcoming formidable obstacles. From streamlining diagnostic processes to enhancing personalized treatment plans, the transformative potential of AI in healthcare is both profound and far-reaching. As we delve into the boundless possibilities that AI offers, we uncover a new frontier in healthcare delivery, one that is marked by efficiency, accuracy, and ultimately, improved patient outcomes.



CSE:TRUE AI is a pioneering company harnessing the power of AI to revolutionize the healthcare landscape, addressing existing inefficiencies and obstacles. Over the course of 7+ years, with insights from hundreds of global healthcare professionals, AI has developed the Global Library of Medicine (GLM), hailed as the most advanced, personalized healthcare AI engine worldwide. Offering unparalleled clinical information and support to healthcare professionals, the GLM boasts an impressive >92% accuracy rate on initial diagnoses and provides recommendations for physical and lab tests, x-rays, and billing codes. What sets the platform apart is its unmatched quality and transparency, with the GLM furnishing explanations for each step and the likelihood associated with every symptom.


As per Statista’s findings, the artificial intelligence (AI) healthcare market, valued at $11 billion in 2021, is forecasted to soar to $187 billion by 2030. This substantial growth indicates an ongoing transformation in the operations of medical providers, hospitals, pharmaceutical and biotechnology companies, and other stakeholders in the healthcare sector. The projected surge underscores the pivotal role AI is poised to play in reshaping healthcare delivery, diagnosis, treatment, and overall patient care. With such significant expansion on the horizon, it’s evident that AI will continue to drive innovation and efficiency, leading to profound changes in how healthcare services are rendered and accessed globally.


Key Potential


Virtual Nursing Assistants

  • AI-powered virtual nurse assistants, including chatbots, apps, or other interfaces, offer support by addressing medication queries, forwarding reports to healthcare professionals, and assisting patients in scheduling appointments with physicians. These assistants streamline communication and provide timely assistance to patients, enhancing the efficiency of healthcare delivery.


Fraud Prevention

  • The healthcare industry grapples with substantial fraud, amounting to $380 billion annually. This inflates consumers’ medical premiums and out-of-pocket expenses. 
  • AI implementation can mitigate this issue by identifying irregular or suspicious patterns in insurance claims. This includes detecting billing for costly services or procedures not conducted, unbundling (separately billing for individual steps of a procedure), and unnecessary tests. 
  • By leveraging AI algorithms, healthcare organizations can effectively combat fraud, ensuring the integrity of the healthcare system and reducing financial burdens on patients.


Administrative Workflow 

  • AI plays a crucial role in streamlining administrative tasks within healthcare settings. It aids clinicians in note-taking and content summarization, ensuring thorough medical records. 
  • AI facilitates accurate coding and seamless information sharing between departments and billing systems. 
  • By automating these processes, AI optimizes efficiency and reduces the administrative burden on healthcare professionals, allowing them to focus more on patient care.


Dosage Error Reduction

  • AI offers solutions to mitigate dosage errors, enhancing patient safety. For instance, AI-powered tools can identify errors in self-administration of medications by patients. 
  • A notable example from a study in Nature Medicine revealed that up to 70% of patients do not adhere to insulin prescriptions correctly. 
  • An AI tool, akin to a background application, can monitor a patient’s administration of insulin pens or inhalers and flag any errors.
  • By leveraging AI technology, healthcare providers can intervene promptly to prevent dosage errors and improve medication adherence among patients, ultimately enhancing treatment outcomes.

Moreover, AI is committed to nurturing the next generation of healthcare professionals by providing support to medical and nursing schools, enabling them to augment the clinical skills of their students using the GLM. With a steadfast focus on leveraging AI for societal good, AI endeavors to utilize its GLM platform to advance health equity and inclusion, particularly for marginalized communities.


Recently, Treatment and Novus Health have forged an alliance, merging expertise to serve over 1.5 million members and their families in navigating the complex realm of healthcare. Over the span of 7 years, Treatment has meticulously developed the Global Library of Medicine (GLM), a cutting-edge AI engine fueled by proprietary algorithms and insights from a myriad of global healthcare professionals. Simultaneously, Novus Health has cultivated a reliable navigation platform, revolutionizing healthcare experiences for clients of leading North American Health Insurers.


This partnership isn’t just about joining forces; it’s about exploring symbiotic opportunities such as Health Risk Assessment and Medical Second Opinion services. Moreover, it fosters a close-knit collaboration in testing and innovating new commercial applications or solutions. The overarching mission is clear: to propel forward-thinking solutions that not only benefit both entities but also catalyze positive change within the health insurance market.


In today’s rapidly evolving landscape of healthcare education, Treatment’s Medical Education Suite (MES) stands out as a beacon of innovation, enhancing every facet of clinical content education. From foundational patient interactions to advanced diagnostic evaluations and faculty benchmarking, MES caters to the diverse needs of medical and nursing students alike. Here are some key highlights:


– **Comprehensive Support**: MES is meticulously designed to streamline the entire spectrum of clinical education, offering support for faculty and students alike. By providing a digital self-test companion and facilitating preparation for the Objective Structured Clinical Examination (OSCE), MES ensures a comprehensive learning experience.


Cost and Time Efficiency

With a focus on reducing faculty administration costs and time, MES optimizes educational resources, allowing institutions to allocate their resources more efficiently.


Global Reach

The impact of MES extends beyond borders, with discussions underway to introduce its solutions to schools in the UK and Canada. In the US alone, where the market comprises numerous medical and nursing schools and a vast student population, MES is poised to make a significant difference.


As Treatment looks to the future, it is thrilled to unveil two new subscription-based Software as a Service (SaaS) solutions poised to launch in the latter half of 2024:


AI Patient

Leveraging AI and a comprehensive library of test cases, AI Patient empowers students in their preparation for medical multiple-choice questions (MCQs) and OSCE exams.


AI Doctor in a Pocket

This mobile-friendly clinical decision support tool brings AI-powered assistance to healthcare professionals and students, offering invaluable support in clinical settings.


Both solutions are built upon Treatment’s proprietary Global Library of Medicine (GLM), a cornerstone of excellence in medical information. With input from hundreds of credentialed clinicians worldwide, the GLM ensures the highest caliber of clinical support for healthcare professionals across the globe. As Treatment continues to push the boundaries of healthcare education, these innovative solutions promise to redefine the learning experience for students and professionals alike.


Furthermore, the company has awarded 800,000 Restricted Share Units (RSUs) to consultants and a company officer, each valid for a three-year term. These RSUs were granted in accordance with the company’s share compensation plan, with a portion of them contingent upon meeting vesting conditions. All RSUs are subject to a statutory hold period of four months and one day from the date of issuance.


In addition, Treatment has forged a partnership with aiXplain, a pioneering no-code/low-code integrated AI development platform in the industry. Over the course of 7 years, in collaboration with hundreds of healthcare professionals worldwide and utilizing proprietary algorithms, Treatment has crafted the Global Library of Medicine (GLM), renowned as the world’s most advanced and personalized healthcare AI engine. Through aiXplain’s marketplace, healthcare organizations can now seamlessly access Treatment’s AI engine via its development framework, thereby elevating the standard of clinical diagnosis across various platforms within their organizations.


Additionally, Treatment and aiXplain are poised to explore mutually beneficial international opportunities through this partnership. With a shared vision for the future, both entities aim to provide the GLM in multiple languages, thus expanding its reach and impact.


Furthermore, this collaboration enables aiXplain and Treatment to collaborate closely on testing and developing additional joint commercial applications or solutions. The overarching goal is to foster the development, implementation, testing, validation, and commercialization of innovative solutions that align with the objectives of both companies, thereby proactively influencing the global healthcare market. AI stands as a beacon of innovation in the healthcare sector, harnessing the power of artificial intelligence to revolutionize patient care. 


Over seven years of collaboration with healthcare professionals worldwide, AI has developed the Global Library of Medicine (GLM), an intelligent, personalized AI engine. This engine boasts an impressive >92% accuracy rate on initial diagnoses, providing invaluable support to healthcare professionals in decision-making processes. Additionally, AI extends its impact to medical education, offering solutions like the Medical Education Suite (MES) to enhance clinical content education for students and faculty. With a focus on using AI for good, AI strives to promote health equity and inclusion, making healthcare more accessible to disenfranchised communities.

We will continue to keep you apprised of this developing situation, but ensure to place CSE:TRUE at the top of your watchlist ASAP.


Happy Trading!



Join our exclusive community

Thank you for Joining